ArticleAnnals of medicine2025
Multiparameter MRI-based automatic segmentation and diagnostic models for the differentiation of intracranial solitary fibrous tumors and meningiomas.
Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Deep Learning for Automated Detection and Segmentation of Meningioma on Multiparametric MRI.Journal of imaging informatics in medicine · 2026Article
- Automatic identification of different stage of Alzheimer's disease using multimodal MRI and artificial intelligence.BMC medical imaging · 2026Article
- Individualized prediction of transition from subjective cognitive decline to mild cognitive impairment based on multimodal MRI: a 10-year follow-up study.The journal of prevention of Alzheimer's disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntracranial solitary fibrous tumors (SFTs) and meningiomas are meningeal tumors with different malignancy levels and prognoses. Their similar imaging features make preoperative differentiation difficult, resulting in high misdiagnosis rates. Thus, accurately distinguishing SFTs from meningiomas preoperatively is vital for surgical planning and treatment strategies. PATIENTS AND
methodsA total of 252 patients (56 SFTs and 196 meningiomas) data from January 2014 to May 2024 were used to train our models . A VB-Net deep learning network was employed to refine automatic segmentation. To identify SFTs and meningiomas, the segmented data were analyzed using machine learning to construct single-sequence and multi-sequence MRI models and combined with clinical/radiological features to develop a fusion index-related model.To enhance clinical applicability, we constructed a four-category model using the predictive probabilities from secondary classification as input features.
resultsThe VB-Net segmentation model performed well in both the tumor cores and the whole tumor, with DSCs of 0.87 (±0.17) and 0.79 (±0.26), respectively. The integration of clinical and radiological data enhanced the model's AUC to 0.957. Stratified analysis showed that the weighted AUC value reached 0.846 in the validation set.
conclusionThe comprehensive system integrating automatic segmentation with diagnostic models can differentiate SFTs from meningiomas precisely.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.